Clinical Trials List
Protocol NumberPOLARIS2016-002
Completed
2017-06-08 - 2019-12-31
Phase I
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Shang-Hung Chen Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Hui-Jen Tsai Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- Kwang-Yu Chang Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Nai-Jung Chiang Division of Hematology & Oncology
- Yan-Shen Shan Division of General Surgery
- 劉奕廷 Division of Hematology & Oncology
- 姜乃榕 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6~76 participants
-
Global
6~76 participants
